S2 Genomics, Inc. Announces Distribution Partnerships With SCRUM, PharmiGene, LnCBio, Thunderbio Science, and TrendBio
September 09, 2020 at 09:56 pm IST
Share
S2 Genomics, Inc. announced that it has entered into distribution agreements with SCRUM, PharmiGene, LnCBio, Thunderbio Science, and TrendBio for the promotion, sales, and support of S2’s Singulator™ 100 System and associated products for single-cell genomics and cell biology applications in the Asia-Pacific region. The distribution agreements cover Japan (SCRUM), South Korea (LnCBio and Thunderbio Science), Taiwan (PharmiGene), and Australia and New Zealand (TrendBio).
Pharmigene Inc is mainly engaged in drug gene diagnosis, functional medical testing services and agency sales of laboratory equipment and consumables. The Company mainly engages in field of genomics science, developing professional drug genetic diagnostic kits, testing technologies, and overall solutions for the research and development of drug genomics in precision medicine. The Company's molecular diagnostic products mainly include AutoEx16 automatic nucleic acid extractor, Clopidogrel drug effectiveness gene CYP2C19*2&*3 test kit, SGE 1502 test suite, SGE 3101 test suite, SGE 5701 test suite, Sega 5801 test kit, SGE B27 test kit, SGE whole blood calculation and extraction kit and others. Testing services include drug genetic testing projects, functional medical testing projects and personalized genetic testing. The Company mainly distributes its products in Taiwan market and other markets.
PHARMIGENE, INC. 
